Extracapsular invasion of lymph node metastasis: A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma

Cancer

Volumn 86, Issue 5, 1999, Pages 842-849

  Yamashita, Hiroto ^a,b   Noguchi, Shiro ^a   Murakami, Nobuo ^a   Toda, Masakatus ^a   Yamashita, Hiroyuki ^a   Uchino, Sinya ^a   Watanabe, Shin ^a   Kawamoto, Hitoshi ^a  

^a Noguchi Thyroid Clin/Hosp Found   (Japan)

^b Noguchi Thyroid Clin/Hosp Found   (Japan)

Author keywords

Extracapsular invasion; Lymph node metastasis; Microcarcinoma; Prognosis; Thyroid carcinoma

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; DISEASE MARKER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REGRESSION ANALYSIS; RISK FACTOR; THYROID CARCINOMA; TUMOR RECURRENCE;

ADULT; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; THYROID NEOPLASMS;

EID: 0033198125     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990901)86:5<842::AID-CNCR21>3.0.CO;2-X     Document Type: Article

References (51)

1. Woolner LB, Lemmon ML, Beahrs OH, Black BM, Keating FR Jr. Occult papillary carcinoma of the thyroid gland: a study of 140 cases observed in a 30 year period. J Clin Endocrinol 1960;20:89-105.
2. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. 2nd ed. World Health Organization. New York: Springer-Verlag, 1988:9-11.
3. Hubert JP, Kicrnan PD, Bearhrs OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg 1980;115:394-8.
4. Schroder S, Pfannschmidt N, Bocker W, Muller HW, de Heer K. Histopathologic types and clinical behavior of occult papillary carcinoma of the thyroid. Pathol Res Pract 1984; 179:81-7.
5. Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B. High prevalence of occult papillary carcinoma in a surgical series for benign thyroid disease. Tumori 1990;76: 255-7.
6. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;112: 1139-47.
7. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid - a long-term follow-up of 867 patients. Arch Surg 1996;31:87-91.
8. Naurse, Koike A, Kanemitsu T, Kato K. Minimal thyroid carcinoma: a report of nine cases discovered by cervical lymph node metastasis. Jpn J Surg 1984;14:118-21.
9. Aldabagh SM, Trujillo YP, Taxy JB. Occult medullary thyroid carcinoma. Unusual histologic variant presenting with metastatic disease. Am J Clin Pathol 1986;85:247-50.
10. Park CS, Min JS. Lateral neck mass as the initial manifestation of thyroid carcinoma. Head Neck 1989;11:410-3.
11. Nussbaum M, Bukachevsky R. Thyroid carcinoma presenting as a regional neck mass. Head Neck 1990;12:114-7.
12. Satge D, Grob JC, Pusel J, Methlin G. Microcarciome thyroidien D'e'volution fatale. Arch Anat Cytol Pathol 1990;38: 143-51.
13. Hazard JB. Small papillary carcinoma of the thyroid: a study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest 1960;9:86-97.
14. McConahey WM, Hay ID, Woolner LB, van Heerdan JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic 1946 through 1970: initial manifestation, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61: 978-96.
15. Omata K, Mochizuki K, Chino M, Iguchi K, Iida R, Watanabe H, et al. Detection of thyroid cancer in mass screening using ultrasonic echography and aspiration biopsy cytology. J Jpn Soc Clin Cytol 1985;24:680-5.
16. Ishida T, Izuo M, Ogawa T, Kurebayashi J, Satoh K. Evaluation of mass screening for thyroid cancer. Jpn J Clin Oncol 1988;18:289-95.
17. International Union Against Cancer. In: Hermanek P, Sobin LH, editors. TMN classification of malignant tumors. 4th ed. 2nd revision. Berlin: Springer-Verlag, 1992:35-7.
18. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S. Extra capsular invasion of nodal metastasis is an indicator of distant metastasis and poor prognosis of patients with thyroid papillary carcinoma. Cancer 1997;80: 2268-72.
19. Burt A, Goudie RB. Diagnosis of primary thyroid carcinoma by immunohistological demonstration of thyroglobulin. Histopathology 1979;3:279-86.
20. Mendelsohn G, Eggleston JC, Weisburger WR, Gann DS, Baylin SB. Calcitonin and histaminase in C-cell hyperplasia and thyroid carcinoma. A light microscopic and immunohistochemical study. Am J Pathol 1978;92: 35-43.
21. DeLellis RA, Rule AH, Spiler I, Nathanson L, Tashjian AH, Wolfe HJ. Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 1978;70:589-94.
22. De Micco C, Ruf J, Chrestian MA, Gros N, Henry JF, Carayon P. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic and neoplastic human thyroid tissues. Cancer 1991;67:3036-41.
23. Yamashita H, Noguchi S, Murakami N, Adachi M, Maruta J. Immunohistological differentiation of benign thyroid follicular cell tumors from malignant ones: usefulness of antiperoxidase and JT-95 antibodies. Acta Pathol Jpn 1993;43: 46-9.
24. Hosoya T, Sakurai K. Histochemical response of papillary thyroid carcinomas to the monoclonal antibody (JT-95). Gann no Rinsho 1991;37:721-4.
25. Takeyama H, Hosoya T, Sakurai K, Mori Y, Watanabe M, Kisaki H, et al. Production of a novel monoclonal antibody, JT-95, which can detect antigen of thyroid carcinoma. Cancer Res 1996;56:1817-22.
26. Pizzolo G, Sloane J, Beverly P. Differential diagnosis of malignant lymphoma and nonlymphoid tumors using monoclonal antileucocyte antibody. Cancer 1980;46: 2640-7.
27. Faure P, Chittal S, Woodman-Memeteau W, Caveriviere P, Gorguest B, Voigt JJ, et al. Diagnostic features of primary malignant lymphoma of the thyroid with monoclonal antibodies. Cancer 1988;61:1852-61.
28. Cox DR. Regression model and life-tables. J R Stat Soc B 1972;34:187-220.
29. Siegel S. Nonparametric statistics for the behavioral sciences. International student edition. Tokyo: McGraw-Hill Kogausha, 1965:213-23.
30. Chan JK. Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 1990;5:241-57.
31. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2:851-6.
32. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363(6428):458-60.
33. SAS institute Inc. 1995 JMP statistics and graphics guide, version 3.1. Cary, NC: SAS Institute Inc.
34. Cox DR, Oakes D. 1984 Analysis of survival data. London: Chapman and Hall.
35. Tschawrakow G, Welkow M. Uber das Grahms-Karizom der Schildddruse. Zentralbl Pathol 1991;137:78-81.
36. Lissak B, Vannetzel JM, Gallouedec N, Berrod JL, Rieu M. Solitary skin metastasis as the presenting feature of differentiated thyroid microcarcinoma: report of two cases. J Endocrinol Invest 1995;18:813-6.
37. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, et al. Clinical presentations and predictive variable of thyroid microcarcinoma with distant metastasis. Int Surg 1997;82: 378-381.
38. Rodriguez JM, Moreno A, Parrilla P, Sola J, Soria T, Tebar FJ, et al. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 1997;163:255-9.
39. Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol 1995;48:1495-501.
40. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:1503-10.
41. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
42. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Result (SEER) Program 1973-1991. Cancer 1997;79: 564-73.
43. Schelfhout LJ, Creutzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J, et al. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988; 24:331-7.
44. Sugitani I, Yanagisawa A, Shimizu A, Kao M, Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 1988;22:731-7.
45. Akazaki K, Kajita A, Higo N. An autopsy case of microscopic sized thyroid carcinoma characterized by generalized bone metastasis. Syujyutu 1960;14:66-71.
46. Patchefsky AS, Keller IB, Mansfield CM. Solitary vertebral column metastasis from occult sclerosing carcinoma of the thyroid gland: report of a case. Am J Clin Pathol 1970;53: 596-601.
47. Levi E. Carcinoma of the thyroid with metastasis to lungs. NY State J Med 1975;75:1544-6.
48. Boehm T, Rothouse L, Wartofsky L. Metastatic occult follicular thyroid carcinoma. JAMA 1976;235:2420-1.
49. Jancic-Zgurias M, Jankovic R. Occult papillary carcinoma of the thyroid gland revealed by cancer pericarditis. Pathol Res Pract 1986;181:761-4.
50. Michie HR, O'Bryan-Tear CG, Marsh H, Glazer G. Cerebral metastasis from occult papillary carcinoma of the thyroid. Br J Surg 1987;74:647-7.
51. Lin KD, Lin JD, Huang HS, Jeng LB, Ho YS. Skull metastasis with brain invasion from thyroid papillary microcarcinoma. J Fromos Med Assoc 1997;96:280-2.